Search

Your search keyword '"S. Lobello"' showing total 64 results

Search Constraints

Start Over You searched for: Author "S. Lobello" Remove constraint Author: "S. Lobello"
64 results on '"S. Lobello"'

Search Results

1. Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy

2. THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients

3. THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy

4. Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients

5. SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy

7. EPIDEMIOLOGY

12. Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group

13. Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto network

14. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study

15. A cost-consequence analysis of screening and treatment for chronic hepatitis B (CHB) virus infection in resident immigrants of an Italian North-East

16. Chronic Hepatitis D: A Vanishing Disease? An Italian Multicenter Study

17. LP52 : Nonalcoholic fatty liver disease (NAFLD) as potential risk factor of cardiovascular disease and oncological disease in diabetic type 2 patients

18. Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring

19. Hepatitis C virus in healthy immigrants: To screen or not to screen?

20. YIS-4SOCIAL AND HEALTH INTEGRATED APPROACH TO ALCOHOL USE DISORDERS (AUDs) AND ALCOHOL ABUSE/DEPENDENCE: AN ITALIAN EXPERIENCE IN A SPECIALIST SERVICE

21. O6 * FREE ORAL COMMUNICATIONS 6: PSYCHOSOCIAL FACTORS AND ALCOHOL USE DISORDERS

22. O4 * FREE ORAL COMMUNICATIONS 4: ALCOHOL INTERVENTIONS IN DIFFERENT SETTINGS

25. Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene

26. 825 SILYBIN CONJUGATED WITH PHOSPHATIDYLCHOLINE AND VITAMIN E IMPROVES LIVER DAMAGE IN PATIENTS WITH NAFLD: THE RESULTS OF A RANDOMIZED MULTICENTRE DOUBLE-BLIND VS PLACEBO TRIAL

27. P1282 A COST–CONSEQUENCE ANALYSIS OF SCREENING AND TREATMENT FOR CHRONIC HEPATITIS B (CHB) VIRUS INFECTION IN RESIDENT IMMIGRANTS OF AN ITALIAN NORTH-EAST REGION

28. Hepatitis B virus screening in healthy immigrants: A strategy to prevent the spread of infection and to identify and manage chronic hepatitis B (CHB)

29. Preliminary results of a two-center trial with colchicine for the treatment of chronic hepatitis B

30. High-fat diet and the risk for non-alcoholic fatty liver disease: A population-based study

32. P.18.1 A PROPER ORGANIZATIONAL MODEL ENCOURAGES HIGH RATE OF INTENTION-TO-TREAT SUSTAINED VIROLOGICAL RESPONSE IN AN INJECTING DRUG USERS HCV+ POPULATION

34. OC8 SCREENING FOR HBV IN IMMIGRANTS: PILOT PHASE OF EPIDEMIOLOGICAL STUDY IN HEALTY POPULATION

35. F-49 A randomized multicentre double-blind vs placebo trial: Evaluation of effect of silybin conjugated with phosphatidilcholine and vitamin E on liver damage in patients with nonalcoholic fatty liver disease

36. S1839 Effect of Silybin in Patients With Chronic Hepatitis: Preliminary Results of a Multicentre Randomized Controlled Trial vs Placebo

46. Sustained response to 12-month interferon treatment in patients with chronic hepatitis C: A comparison between different IFN doses

47. Daily interferon monotherapy versus daily interferon plus amantadine in the treatment of naive chronic hepatitis C: End of treatment response

50. Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.

Catalog

Books, media, physical & digital resources